Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Gedea Biotech secures 1.3 MEuros (14 MSEK) to advance its antibiotic-free vaginal infection treatment pHyph towards market launch

Lund, Sweden, May 24, 2023: Gedea Biotech today announced that it has raised 1.3 MEuros (14 MSEK) for additional development activities of their product pHyph for antibiotic free treatment of vaginal infections. The funds will be used for: · An ongoing proof-of-concept study for the treatment of Vulvo Vaginal Candidiasis (VVC) with pHyph, partially financed by a recent grant from Swelife and Medtech4Health · Investigating how the vaginal microbiome changes during short- and long-term treatment with pHyph in patients with bacterial vaginosis · Preparation of an additional clinical

Veg of Lund receives a Swedish patent protecting the company’s plant-based ice cream

The Swedish Intellectual Property Office (PRV) has notified Veg of Lund AB that the authority intends to approve the patent application SE 2250375-9 which defines the company’s unique vegetable ice cream alternative. This means that the upcoming patent protection covers the Swedish market.Veg of Lund’s patent portfolio has been strengthened by the announcement from the Swedish Intellectual Property Office and refers to the company’s vegan ice cream based on a combination of potatoes, rapeseed oil and a vegetable protein in the form of a frozen emulsion. The ice cream has a very creamy

Changes in Caverion’s Group Management Board

Caverion Corporation Stock exchange release 24 May 2023 at 9.30 a.m. EESTChanges in Caverion’s Group Management Board Caverion is continuing the execution of its Sustainable Growth strategy, focusing on creating sustainable impact for every customer with the solutions it designs and delivers, reliably and transparently every time. The following changes in the Caverion Group Management Board will take place as of today on 24 May 2023. Minna Schrey-Hyppänen, Executive Vice President, Human Resources and Safety, has resigned and will leave Caverion. Caverion has appointed Liisa Vasben

BioStock: Well-financed Elicera prepared for clinic and business development

The cell and gene therapy company Elicera Therapeutics has made important progress in two priority areas this year. This concerns investments in business development of the iTANK platform technology and obtaining conditional approval for the start of a phase I/IIa study with the CAR T-cell candidate ELC-301. This means that Elicera is now entering an exciting phase in an area where several significant transactions have been made recently.Read the article at biostock.se:https://www.biostock.se/en/2023/05/well-financed-elicera-prepared-for-clinic-and-business-development 

Mandatory notification of trade

Valter Pasanen, GM Veterinary in Nordhealth AS (the "Company"), has on 23 May 2023 through Oy Pasanen & Co Oy bought a total of 3,800 A shares in the Company at an average price of NOK 21.67 per share. Following the transaction, Valter Pasanen holds a total of 77,443 A shares and 402,796 B shares in the Company through Oy Pasanen & Co Oy. Please see attached notification forms in accordance with the Market Abuse Regulation article 19. For further information, please contact: Mari Orttenvuori, CFO mari.orttenvuori@nordhealth.com +358 46 8765 233

Petra Albuschus, ICA Gruppen’s Chief Human Resources Officer, leaves ICA Gruppen

Petra Albuschus, ICA Gruppen’s Chief Human Resources Officer (CHRO), leaves ICA Gruppen no later than November 2023 to take on the role as Executive Vice President, Human Resources and Sustainability for Autoliv. The recruitment of Petra’s successor will begin immediately.−Petra Albuschus has worked within ICA since 2008, first as logistics director for ICA Sweden, and since 2015 as Chief Human Resources Officer for ICA Gruppen. Among other things, Petra has had a leading role in the strong employer brand position that ICA Gruppen has today. Petra has also implemented ICA Gruppen’s people

XNK Therapeutics to present at ABG Sundal Collier’s Life Science Summit in Stockholm

XNK Therapeutics today announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST.The presentation is followed by a short Q&A session, moderated by an ABGSC analyst, and a recording will be available after the event. For more information, please contact: Johan Liwing, CEO, XNK Therapeutics Tel: +46 706 70 36 75 E-mail: johan.liwing@xnktherapeutics.com About XNK Therapeutics AB XNK Therapeutics is a clinical stage, immunotherapy company focusing its efforts on preventing and treating cancer by

Musti Group's pet food factory Premium Pet Food Suomi Oy has been granted FSSC 22000 and ISO 14001 certifications

Musti Group plc                                                 Press Release                           24 May 2023 at 9.00 a.m. Musti Group's pet food factory Premium Pet Food Suomi Oy has been granted FSSC 22000 and ISO 14001 certifications Musti Group's pet food factory Premium Pet Food Suomi Oy, located in Lieto, Finland, has been granted the FSSC 22000 (Food Safety System Certificate) and the ISO 14001 environmental certificate. The FSSC 22000 certification model is used globally throughout the food chain to ensure food safety standards and processes, from food and feed

Katalysen Ventures announces LOI for merger between Alaco Analytics and VALEGA Chain Analytics

Katalysen Ventures, the leading Nordic venture developer focused on supporting innovative and disruptive companies in early-stages, has signed a Letter of Intent (LOI) for a merger between its venture Alaco Analytics, and VALEGA Chain Analytics (“Valega”, https://www.valegachain.com/), a Finnish firm specializing in digital forensics and investigations.Alaco Analytics was founded as a joint venture between Katalysen Ventures and Alaco Ltd, , a leading business intelligence firm. The merger with Valega will enable the combined entity to leverage Alaco Analytics'

Eurocine Vaccines discloses interim report for July 2022 – March 2023

Eurocine Vaccines AB (publ) (“Eurocine Vaccines” or the “Company”) hereby discloses the interim report for July 2022 to March 2023. Below is a summary of the report. The full report is available on Eurocine Vaccines’ website and as an attachment.2023-01-01 – 2023-03-31 (third quarter) · Results after tax for the quarter amounted to -3.2 MSEK (-5.6 MSEK) · Revenues for the quarter amounted to 2 KSEK (0 KSEK) · Earnings per share for the quarter amounted to -0.115 SEK (-0.397 SEK) 2022-07-01 – 2023-03-31 (nine-month period) · Results after

Petra Albuschus named as next Executive Vice President, Human Resources and Sustainability for Autoliv

(Stockholm, Sweden, May 24, 2023) - Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, announces that Petra Albuschus will join the company as Executive Vice President, Human Resources and Sustainability and will become a member of the Autoliv Executive Management Team. She will succeed Per Ericson who will retire.Petra Albuschus joins Autoliv from Swedish retail company ICA Gruppen AB where she serves as Chief Human Resources Officer and a member of the ICA Gruppen executive management team. In her career, Petra has accumulated valuable

Ductor and TotalEnergies form JV to develop, build and operate a pipeline of biogas and organic fertilizer projects

Ductor, a leading circular biotechnology company within biogas and organic fertilizers, and TotalEnergies, the global multi-energy company, today announce a new commercial and financial partnership with joint development of production facilities and TotalEnergies equity ownership in Ductor.The two companies have agreed to form a joint venture to co-develop and jointly invest in 15 to 20 anaerobic digestion facilities targeting nitrogen rich feedstocks and organic waste from the agricultural sector and turning this into sustainable organic fertilizers and renewable natural gas. The

Höegh LNG: Interim results for the quarter ended 31 March 2023

Hamilton, Bermuda, 24 May 2023 - Höegh LNG Holdings Ltd. ("Höegh LNG") today reports its interim financial results for the quarter ended 31 March 2023. The group reported a total income of USD 137.4 million and an EBITDA of USD 91.9 million for the first quarter of 2023, compared to USD 106.1 million and USD 51.9 million for the preceding quarter. Furthermore, during the quarter the group signed the new loan agreement for refinancing two of its FSRUs and completed the previously announced acquisition of the 2013-built LNG carrier Höegh Gandria (ex. Golar Seal).“We are proud to deliver the

InDex Pharmaceuticals Holding AB (publ) interim report January – March 2023

Positive results from pharmacokinetic study with cobitolimod“We are very excited that the pharmacokinetic study could confirm a low systemic uptake of the higher dose of 500 mg cobitolimod, and that it was well tolerated with no serious adverse events reported in the study,” said Jenny Sundqvist, CEO of InDex Pharmaceuticals. “One of the potential benefits of a locally acting treatment in the colon is low systemic exposure, and with these results we can add another building block to support our excellent safety profile.” Period January – March 2023 · Net sales amounted to SEK 0.0 (0.

STENOCARE Unit Right Issue - First day of subscription

­STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“Stenocare”) announced on May 15, 2023 that the company will raise up to 30 million DDK in a Unit Right Issue on Nasdaq First North Growth Market. Today, May 24, is the first day for investors and shareholders to subscribe for the new shares and Warrants.Market leadership: Stenocare has been a pioneer in the medical cannabis industry since 2017 and has successfully entered 5 countries with subscription-based products that are approved for sales by local health agencies. The European medical cannabis

Delete Group Oyj: Continued strong development, outlook remains good

Delete Group Oyj | Stock Exchange Release | 24 May 2023 at 9:00 a.m. EESTInterim Review January–March 2023 (IFRS, unaudited)   Delete Group Oyj: Continued strong development, outlook remains good     KEY POINTS: JANUARY–MARCH 2023   •         Net sales increased by 8% to EUR 17.0 (Q1 2022: 15.8) million •         EBITDA increased by EUR 1.0 million to EUR 0.0 (-1.0) million •         EBIT increased by EUR 1.1 million to EUR -2.4 (-3.5) million •         Operative cash flow decreased by EUR 2.7 million to EUR -6.1 (-3.4) million •         On 12 May 2023,

EnQuest May Operations Update

EnQuest PLC, 24 May 2023 Operations update Good production performance year to date; full year guidance remains unchanged EnQuest Chief Executive, Amjad Bseisu, commented: "EnQuest has continued to deliver strong operational performance across our operated portfolio during the early part of the year, with production to the end of April above the top end of 2023 guidance. "Production enhancement at Magnus is continuing, following the successful execution of our 2022 planned shutdown and well programme, including the drilling of North West Magnus well. We are now drilling the

Balder establishes its own property management organisation in Finland

During the autumn, Fastighets AB Balder will start its own property management organisation in Finland. This is in order to more effectively and cohesively manage the company’s wholly-owned properties together with the properties which are owned through Serena Properties AB. Juha Lehtonen has been appointed as the CEO of Balder Finland and is now starting the work on building up the new organisation.Balder’s ownership of properties in Finland has gradually increased over the years and as the company owns 99 per cent of Serena Properties since October 2021, Balder estimates that it is more

NRC Group ASA initiates share buyback program

NRC Group ASA (the “Company”) has decided to initiate a share buyback program for up to NOK 7 million in the market.The buyback program will be conducted in accordance with the authorization provided by the Annual General Meeting to the Board of Directors on 4 May 2023. The shares purchased under this program will be used in connection with the Company’s employee share program. The shares will be purchased from the open market, in line with applicable restrictions, relevant guidelines and main safe harbor principles on price and volume limitations. The share buyback program will

Sweco converts existing EUR 400 million revolving credit facility to a sustainability-linked loan

Sweco’s EUR 400 million credit facility is intended to be utilised for the long-term financing of general corporate purposes and acquisitions. The credit is now being linked to the company’s climate and social sustainability agenda.The terms and conditions of the credit facility will be linked to targets for Sweco’s long-term initiatives to reduce GHG emissions in own operations and to increase gender equality among employees.  “Sustainability is integrated in everything we do at Sweco. It is therefore a natural step to link the company’s financing to our sustainability targets,” says

Read original

Wicket Gaming starts a marketing campaign for King Royale on TikTok

From May 24, 2023, Wicket Gaming's free-to-play game King Royale: Idle Tycoon will be promoted on TikTok in collaboration with the agency Wehype. The campaign content has been created by a number of well-known gaming influencers who together have over 3.2 million followers on the platform.After a period of preparation, UGC (User generated Content) marketing campaigns for Wicket Gaming's free-to-play game King Royale are now starting on TikTok. The first period is a test with the ambition to scale up with the content that has given the best results. The strategy of the campaign is in

Glycorex Transplantation AB (publ): Interim Report January – March 2023

January – March 2023 · Net sales: SEK 7.0 million (6.8) · Operating income: SEK -4.3 million (-4.0) · Net income for the period: SEK -4.3 million (-4.1) · Earnings per share: SEK -0.06 (-0.06) Summary of the quarter · 3% sales growth. · The first study on whole blood is published showing that Glycosorb® ABO effectively reduces anti-A/B antibodies without increased haemolysis (destruction of red blood cells). · The first blood group incompatible kidney transplant with Glycosorb® ABO in South Africa is performed. · Great Ormond Street Hospital in England

Change in SRV Group Plc’s Corporate Executive Team

SRV GROUP PLC           STOCK EXCHANGE RELEASE          24 MAY 2023 AT 8:45 EEST   Change in SRV Group Plc’s Corporate Executive Team Henri Sulankivi, SVP, Regional Units and a member of Corporate Executive Team, has decided to leave the company. Until his successor has been elected, SRV Group Plc's Executive Vice President, Strategic Project Development, and a member of the Corporate Executive Team, Hannu Lokka, is responsible for the Regional Units. The recruitment of the new director of the Regional Units will be initiated immediately.  “I thank Henri Sulankivi for his

There are no items matching the current filter
There are no more items matching the current filter
Back to top